GUILFORD, Conn., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (HYPR), the groundbreaking medical device company that created the Swoop ® system, the world's first FDA-cleared portable MRI system, ...
Hyperfine, Inc. announced results from a large data set from an investigator-initiated study evaluating stroke detection with t ...
Rafael O’Halloran, PhD, and Rob Fasciano, PhD, bring depth and breadth of experience in imaging and Medtech. Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has ...
The SAFE MRI ECMO study evaluated the use of ultra-low-field portable MR imaging on ICU patients undergoing extracorporeal membrane oxygenation (ECMO) with an elevated risk of acute brain injury (ABI) ...
GUILFORD, Conn. & ORLANDO, Fla.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world’s first FDA-cleared ...
Interim results from the CARE PMR study support the use of ultra-low-field MRI as a triage tool for monitoring patients on amyloid-targeting therapies. Researchers from the Benzinger Lab at Washington ...
Healthcare technology company Hyperfine announced that the FDA cleared its Optive AI software for its Swoop system, an AI-powered portable MRI system for the brain. The software upgrade marks the ...
Hyperfine Inc., a Guilford-based biotechnology firm, said Thursday it has received approval to market Swoop, its portable imaging device, in the European Union. Hyperfine makes a compact, portable MRI ...
SAN JUAN - Hyperfine, Inc. (NASDAQ:HYPR) announced that its portable Swoop MRI system demonstrated 92% concordance with standard high-field MRI in identifying intracranial pathology, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results